Recent Finacing
Recent Raise
Superluminal Medicines uses a predict‑design‑test platform combining biology, chemistry, ML, and proprietary big‑data infrastructure to model protein structures, design selective small‑molecule GPCR‑targeting compounds, and predict PK/toxicity.
